{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:16:26Z","timestamp":1792588586222,"version":"4.5.0"},"reference-count":53,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["972212 and 971557"],"award-info":[{"award-number":["972212 and 971557"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Chikungunya virus (CHIKV) has caused extensive outbreaks in several countries within the Americas, Asia, Oceanic\/Pacific Islands, and Europe. In humans, CHIKV infections cause a debilitating disease with acute febrile illness and long-term polyarthralgia. Acute and chronic symptoms impose a major economic burden to health systems and contribute to poverty in affected countries. An efficacious vaccine would be an important step towards decreasing the disease burden caused by CHIKV infection. Despite no licensed vaccine is yet available for CHIKV, there is strong evidence of effective asymptomatic viral clearance due to neutralising antibodies against the viral structural proteins. We have designed viral-vectored vaccines to express the structural proteins of CHIKV, using the replication-deficient chimpanzee adenoviral platform, ChAdOx1. Expression of the CHIKV antigens results in the formation of chikungunya virus-like particles. Our vaccines induce high frequencies of anti-chikungunya specific T-cell responses as well as high titres of anti-CHIKV E2 antibodies with high capacity for in vitro neutralisation. Our results indicate the potential for further clinical development of the ChAdOx1 vaccine platform in CHIKV vaccinology.<\/jats:p>","DOI":"10.3390\/v11040322","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T03:13:42Z","timestamp":1554347622000},"page":"322","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-2341","authenticated-orcid":false,"given":"C\u00e9sar","family":"L\u00f3pez-Camacho","sequence":"first","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-9407","authenticated-orcid":false,"given":"Young Chan","family":"Kim","sequence":"additional","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"},{"name":"Division of Structural Biology, University of Oxford, Wellcome Centre for Human Genetics, Roosevelt Drive, Headington, Oxford, OX3 7BN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3624-7008","authenticated-orcid":false,"given":"Joshua","family":"Blight","sequence":"additional","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"},{"name":"Department of Life Sciences, Imperial College London, Sir Alexander Fleming Building, Exhibition Road, South Kensington, London, SW7 2AZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Lazaro Moreli","sequence":"additional","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"},{"name":"Virology Laboratory, Federal University of Goi\u00e1s, Jata\u00ed 75801615, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Montoya-Diaz","sequence":"additional","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"},{"name":"Veterinary Medicine Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, 63225, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-7323","authenticated-orcid":false,"given":"Juha","family":"T Huiskonen","sequence":"additional","affiliation":[{"name":"Division of Structural Biology, University of Oxford, Wellcome Centre for Human Genetics, Roosevelt Drive, Headington, Oxford, OX3 7BN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Mareike K\u00fcmmerer","sequence":"additional","affiliation":[{"name":"Institute of Virology, University of Bonn Medical Centre, Bonn 53127, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Reyes-Sandoval","sequence":"additional","affiliation":[{"name":"The Jenner Institute, Nuffield Department of Medicine, University of Oxford. The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","unstructured":"Schmaljohn, A.L., and McClain, D. (1996). Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3201\/eid2104.141723","article-title":"Reappearance of chikungunya, formerly called dengue, in the Americas","volume":"21","author":"Halstead","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-virology-101416-041757","article-title":"The Bridges and Blockades to Evolutionary Convergence on the Road to Predicting Chikungunya Virus Evolution","volume":"4","author":"Vignuzzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"ref_5","first-page":"82","article-title":"Chikungunya: Epidemiology","volume":"5","author":"Petersen","year":"2016","journal-title":"Research"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: Evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_7","first-page":"270","article-title":"Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review","volume":"41","author":"Cella","year":"2016","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.2174\/13816128113199990379","article-title":"Genomes to hits in silico\u2014A country path today, a highway tomorrow: A case study of chikungunya","volume":"19","author":"Soni","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of chikungunya: A re-emerging arbovirus","volume":"393","author":"Solignat","year":"2009","journal-title":"Virology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.virol.2017.12.020","article-title":"Structure-function insights into chikungunya virus capsid protein: Small molecules targeting capsid hydrophobic pocket","volume":"515","author":"Sharma","year":"2018","journal-title":"Virology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00435","DOI":"10.7554\/eLife.00435","article-title":"Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization","volume":"2","author":"Sun","year":"2013","journal-title":"eLife"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00303-8","article-title":"The Fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH","volume":"105","author":"Lescar","year":"2001","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.virol.2004.11.043","article-title":"Heparin binding sites on Ross River virus revealed by electron cryo-microscopy","volume":"332","author":"Zhang","year":"2005","journal-title":"Virology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1590\/0037-8682-0246-2014","article-title":"Emerging alphaviruses in the Americas: Chikungunya and Mayaro","volume":"47","author":"Figueiredo","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: An update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/0037-8682-0479-2016","article-title":"de Alert: Severe cases and deaths associated with Chikungunya in Brazil","volume":"50","author":"Brito","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1179\/2047773214Y.0000000163","article-title":"Dengue and chikungunya: Long-distance spread and outbreaks in na\u00efve areas","volume":"108","author":"Rezza","year":"2014","journal-title":"Pathog. Glob. Health"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Reyes-Sandoval, A. (2019). 51 years in of Chikungunya clinical vaccine development: A historical perspective. Hum. Vaccines Immunother.","DOI":"10.1080\/21645515.2019.1574149"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","article-title":"Development of vaccines for chikungunya fever","volume":"214","author":"Erasmus","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rezza, G., and Weaver, S.C. (2019). Chikungunya as a paradigm forz emerging viral diseases: Evaluating disease impact and hurdles to vaccine development. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0006919"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Milligan, G.N., Schnierle, B.S., McAuley, A.J., and Beasley, D.W.C. (2018). Defining a correlate of protection for chikungunya virus vaccines. Vaccine, in Press.","DOI":"10.1016\/j.vaccine.2018.10.033"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pal, P., Dowd, K.A., Brien, J.D., Edeling, M.A., Gorlatov, S., Johnson, S., Lee, I., Akahata, W., Nabel, G.J., and Richter, M.K.S. (2013). Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003312"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection","volume":"205","author":"Kam","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yoon, I.K., Alera, M.T., Lago, C.B., Tac-An, I.A., Villa, D., Fernandez, S., Thaisomboonsuk, B., Klungthong, C., Levy, J.W., and Velasco, J.M. (2015). High Rate of Subclinical Chikungunya Virus Infection and Association of Neutralizing Antibody with Protection in a Prospective Cohort in The Philippines. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003764"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/s41467-018-04859-5","article-title":"Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors","volume":"9","author":"Abbink","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W550","DOI":"10.1093\/nar\/gkx273","article-title":"Programmatic access to bioinformatics tools from EMBL-EBI update: 2017","volume":"45","author":"Chojnacki","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1107\/S0907444906029799","article-title":"A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr","volume":"62","author":"Aricescu","year":"2006","journal-title":"D Biol. Crystallogr."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gl\u00e4sker, S., Lulla, A., Lulla, V., Couderc, T., Drexler, J.F., Liljestr\u00f6m, P., Lecuit, M., Drosten, C., Merits, A., and K\u00fcmmerer, B.M. (2013). Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol. J., 10.","DOI":"10.1186\/1743-422X-10-235"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Saraswat, S., Athmaram, T.N., Parida, M., Agarwal, A., Saha, A., and Dash, P.K. (2016). Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004782"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jgm.582","article-title":"Vesicular stomatitis virus glycoprotein: A transducing coat for SFV-based RNA vectors","volume":"6","author":"Dorange","year":"2004","journal-title":"J. Gene Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tuekprakhon, A., Puiprom, O., Sasaki, T., Michiels, J., Bartholomeeusen, K., Nakayama, E.E., Meno, M.K., Phadungsombat, J., Huits, R., and Ari\u00ebn, K.K. (2018). Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208851"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Berthoud","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/jvi.65.1.147-154.1991","article-title":"Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor","volume":"65","author":"Garoff","year":"1991","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JVI.01860-12","article-title":"A Chimeric Vesiculo\/Alphavirus Is an Effective Alphavirus Vaccine","volume":"87","author":"Chattopadhyay","year":"2012","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/JVI.03418-13","article-title":"A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection","volume":"88","author":"Cepeda","year":"2014","journal-title":"J. Virol."},{"key":"ref_45","first-page":"259","article-title":"A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hoarau, J.J., Gay, F., Pell\u00e9, O., Samri, A., Jaffar-Bandjee, M.C., Gasque, P., and Autran, B. (2013). Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005\u20132006 in La Reunion Island. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084695"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e83527","DOI":"10.1172\/jci.insight.83527","article-title":"Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus","volume":"2","author":"Roques","year":"2017","journal-title":"JCI Insight"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1128\/JVI.01926-14","article-title":"Prime-boost immunization strategies against Chikungunya virus","volume":"88","author":"Lum","year":"2014","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3201\/eid1403.070906","article-title":"Chikungunya fever in travelers returning to Europe from the Indian Ocean Region, 2006","volume":"14","author":"Panning","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: A phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3201\/eid1210.060078","article-title":"Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa","volume":"12","author":"Xiang","year":"2006","journal-title":"Emerg. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/4\/322\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:39Z","timestamp":1760186559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/4\/322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["v11040322"],"URL":"https:\/\/doi.org\/10.3390\/v11040322","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]}}}